MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
2. Industry_Business Architects & Consolidators
Industry: By Region (Globally)
Industry: U.S.(United States)
Industry: Mid Atlantic
Industry: New York
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT)*
Organization & Developments: ALIXTE Biotechnology
Parents
LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT)*
Children
LB-100 to treat cancer showing evidence of DNA damage and mitotic stress
Lixte has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, that has potential widespread use as an anti-cancer agent alone and in combination with standard anti-cancer cytotoxic drugs, radiation, and immune checkpoint blockers
Jumps
Finance & Acquisitions: LIXTE Biotechnology
Key People: LIXTE Biotechnology